Congress recognizes hepatitis crisis, calls for expanded vaccination and treatment

What it does

This resolution recognizes July 28, 2025, as World Hepatitis Day and calls on the federal government to increase awareness, vaccination, and treatment access for hepatitis B and C. It highlights that an estimated 5.9 million Americans live with chronic hepatitis B or C, with disproportionate impact on communities of color, people who inject drugs, and people living with HIV, and urges the CDC to work with state and local health departments to expand vaccination and treatment programs.

Why we flagged it

This is a straightforward commemorative resolution designating a day of recognition and calling for expanded public health action on viral hepatitis. It contains no legislative mechanism, appropriations, or regulatory change—only symbolic recognition and hortatory language urging federal agencies to act.

What the text implies

• The resolution's emphasis on health disparities and underdiagnosis may create political pressure for CDC funding increases or new hepatitis elimination initiatives, though the resolution itself does not appropriate funds.
• By calling for universal adult hepatitis B vaccination (shifting from risk-based to universal screening), the resolution implicitly endorses a significant expansion of public health infrastructure and vaccine distribution that would require sustained funding and coordination.
• The resolution highlights that over half of people with hepatitis B or C are unaware of their infection, potentially signaling a need for expanded screening programs in primary care and community health settings.

Who it affects

The resolution advances public health by raising awareness of a significant but under-recognized disease burden, calling for expanded vaccination and treatment access, and highlighting health disparities. It imposes no costs on citizens and supports evidence-based interventions (universal vaccination, treatment access, harm reduction) that would reduce disease and death.

Who stands to gain

• vaccine manufacturers (hepatitis B vaccine producers)
• antiviral drug manufacturers (hepatitis C treatment providers)
• public health agencies and community health centers (if funding follows)

Named in the bill

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), Advisory Committee on Immunization Practices (ACIP), state and local health departments, community-based organizations

Where it stands

1 cosponsor: 1 Democrats.

• Aug 1, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.